Social Determinants of Health in People Living with Psychiatric Disorders: The Role of Pharmacists
- PMID: 37096056
- PMCID: PMC10122249
- DOI: 10.1089/heq.2022.0189
Social Determinants of Health in People Living with Psychiatric Disorders: The Role of Pharmacists
Abstract
Introduction: Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication optimization, pharmacists play a vital role in identifying and addressing medication-related problems associated with SDOH. However, there is a paucity of literature on how pharmacists can be part of the solution.
Objective: The purpose of this article is to provide a narrative review and commentary on the intersection between SDOH, medication-related outcomes in people living with psychiatric disorders, and the role of pharmacists in addressing them.
Method: The American Association of Psychiatric Pharmacists appointed an expert panel to research the issue, identify barriers, and develop a framework for including pharmacists in addressing medication therapy problems associated with SDOH in people with psychiatric disorders. The panel used Healthy People 2030 as the framework and sought input from public health officials to propose solutions for their commentary.
Results: We identified potential connections between SDOH and their impact on medication use in people with psychiatric disorders. We provide examples of how comprehensive medication management can afford opportunities for pharmacists to mitigate medication-related problems associated with SDOH.
Conclusion: Public health officials should be aware of the vital role that pharmacists play in addressing medication therapy problems associated with SDOH to improve health outcomes and to incorporate them in health promotion programs.
Keywords: clinical pharmacists; community pharmacists; healthy people programs; psychiatric disorders; public health; social determinants of health.
© Carla D. Cobb et al., 2023; Published by Mary Ann Liebert, Inc.
Conflict of interest statement
C.D.C. is a stockholder in Abbott, Amgen, Astra Zeneca, Eli Lilly, Gilead, Johnson & Johnson, Merck, Moderna, Proctor and Gamble, Moderna, and Seagen. C.A.O. is an expert panelist for the Indiana University School of Medicine Project ECHO for Opioid Use Disorders; an expert panelist for the Indiana University Fairbanks School of Public Health Project ECHO for LGBTQ+ Health; serves on the Indiana Medicaid Drug Utilization Review Board, Mental Health Quality Advisory Committee, and Psychotropic Medication Advisory Committee; is a consultant for Wolters-Kluwer/Lexi-Comp; is President of the NAMI West Central Indiana Board of Directors; serves on the Psychopharmacology Consultation Team—Indiana University School of Medicine Department of Psychiatry, Indiana Department of Child Services; and receives grant funding from SAMHSA. No other author reports any relevant disclosures.
Figures
References
-
- World Health Organization. Social Determinants of Health. 2023. Available from: https://www.who.int/health-topics/social-determinants-of-health [Accessed March 30, 2023].
-
- Social Determinants of Health—Healthy People 2030 | health.gov. 2023. Available from: https://health.gov/healthypeople/priority-areas/social-determinants-health [Accessed March 30, 2023].
-
- Understanding the Social Determinants of Health. AAF. 2018. Available from: https://www.americanactionforum.org/research/understanding-the-social-de... [Accessed June 16, 2022].
Publication types
LinkOut - more resources
Full Text Sources
Research Materials